Effectiveness of Structured Skin Care Using Silicone Barrier Spray Compared with Zinc Oxide Ointment for Incontinence-Associated Dermatitis in Long-Term Care Residents: A Randomized Controlled Trial.

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

Who Took Part

By PubMed's age tags, the people studied were older adults and people over 80, both men and women.

Forty residents with mild IAD (GLOBIAD Category 1) were randomly assigned in a 1:1 ratio to receive either a silicone-based barrier spray (n = 20) or zinc oxide ointment (n = 20), in addition to standardized cleansing care.

How the Study Was Run

The researchers set it up as a randomized study.

Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.

The researchers conducted a 14-day prospective, randomized controlled trial in a long-term care facility.

IAD severity was assessed using the modified Ghent Global IAD Monitoring Tool (GLOBIAD-M).

Secondary outcomes included skin hydration, transepidermal water loss (TEWL), skin pH, and skin temperature, measured at baseline, Day 7, and Day 14.

Longitudinal changes were analyzed using generalized estimating equations.

What Was Measured

Topics PubMed links to this paper include Zinc Oxide, Silicones, Skin Care, Urinary Incontinence, Long-Term Care, Fecal Incontinence and Dermatitis.

The authors tagged it with the keywords incontinence-associated dermatitis, nursing care, silicone spray and skin barrier.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc.

Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2026 (International journal of medical sciences), a journal based in Australia.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.